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Background
The broadly neutralizing antibody 2G12 is uniquely capa-
ble of recognizing the self-carbohydrate shield on the
HIV-1 envelope glycoprotein gp120 and escaping
immune tolerance. The preferred substrate of 2G12 is the
Man4(D1)-arm of high-mannose glycans clustered on the
gp120 outer surface. Remarkably, 2G12 has been shown
to exhibit higher affinity for the non-self monosaccharide
D-fructose than for D-mannose. D-fructose, in its pyran-
ose form, resembles D-mannose, but with different substi-
tutions at the anomeric and C-5 positions. These
observations suggested other 'non-self' modifications to
D-mannose may also enhance 2G12 binding. We conse-
quently found that D-mannose with a C-6 methyl substi-
tution binds 2G12 more strongly than both D-mannose
and D-fructose. Moreover, introduction of this non-self
modification to the terminus of the D1-arm creates the
most potent monovalent 2G12 ligand known. We
uncover here the molecular basis of this enhanced anti-
genicity, and the higher affinity of 2G12 for D-fructose
over D-mannose, through high resolution crystallo-
graphic analyses.
Methods
Crystal structures of 2G12 in complex with the modified
D-mannose and D1-arm, and D-fructose were determined
to 1.75, 2.85, and 1.95 Å, respectively.
Results
The crystal structures of 2G12 in complex with the modi-
fied D-mannose and D1-arm revealed the C-6 methyl sub-
stitution enhances antigenicity by making additional
hydrophobic contacts with the aromatic side chain of
TyrL94. The D1-arm mimic otherwise adopts the same
conformation as the natural D1-arm in complex with
2G12. The complex with D-fructose revealed the non-self
monosaccharide is indeed bound in its pyranose form
and its enhanced antigenicity is due to several additional
H-bonds mediated by its C-5 hydroxyl.
Conclusion
The crystal structures reported here uncover different
mechanisms for creating potent non-self monosaccharide
antigens of 2G12. The fact the D1-arm mimic maintains
the same interactions with 2G12 as the natural D1-arm is
encouraging in terms of its potential as an immunogenic
fragment to elicit a 2G12-like immune response.
from AIDS Vaccine 2009
Paris, France. 19–22 October 2009
Published: 22 October 2009
Retrovirology 2009, 6(Suppl 3):P323 doi:10.1186/1742-4690-6-S3-P323
<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S3/P323
© 2009 Fulton et al; licensee BioMed Central Ltd. 
